Not trying to belabor any points here, but:
I did email Tom Newberry this afternoon asking one question: is the original potential partner still in the mix? I just received this response (words in bold are his):
As Dr. Cox stated in the conference call:
“Keeping our attention on ATryn in the US, we continue in late stage discussions with a potential commercialization and development partner for this country. While we had hoped to be able to complete this negotiation by this time, our potential partner became diverted for a time by other corporate activities. However, we now have broader interest from additional potential partners. This additional interest re-inforces our confidence that we can successfully complete a partnering arrangement for ATryn in the US. Our objective is to complete these negotiations this quarter.“
Best regards,
Tom
